Archives

Lipid nanoparticles protect novel RNA-based drugs and deliver them to their sites of action in the body. ISAR Bioscience aims to reduce side effects and to make them more powerful.

ISAR Bioscience aims to teach iPS cells how to fight autoimmune diseases in an effective and sustained manner.

ISAR Bioscience develops novel antibodies directed against a protein relevant for Alzheimer’s disease. First results are encouraging.

ISAR Bioscience develops new therapies based on ist research projects. Our focus is on three preclinical development projects.

Great recognition: Martha Sommer, team leader at ISAR Bioscience, has been invited to present the UniSens project at the Summit of the European Innovation Council on April 2, 2025.

ISAR Bioscience congratulates Maria-Elena Torres-Padilla, Member of the Board of the Foundation, on winning the Leibniz Prize 2025.

The foundation's board of trustees has appointed Dr. Barbara Krebs-Pohl to succeed Prof. Waldmann on the foundation's board of directors.